Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Bharat Biotech to make 700 million doses in 2021
Dr Krishna Ella, Chairman and MD Bharat Biotech said that Covaxin trials '200 per cent honest'
Mixed reactions from healthcare experts, activists over REU for Covaxin, Covishield
Some ask for more transparency in the approval process and seek data related to vaccine trials while others say that grant of REU…
US may halve doses of Moderna vaccine to speed rollout: Moncef Slaoui
Moncef Slaoui, Head of Operation Warp Speed, said that officials were in talks with Moderna and the Food and Drug Administration…
Sun Pharma starts Phase II trial of SCD-044 for moderate to severe plaque psoriasis
SCD-044 is also being evaluated in other autoimmune disorders and Phase 2 studies for other indications like atopic dermatitis,…
Tel Aviv University develops novel lipid nanoparticle-based delivery system to destroy cancer cells
The system, called CRISPR-LNPs, carries a genetic messenger (messenger RNA), which encodes for the CRISPR enzyme Cas9 that acts as…
Angelini Pharma acquires Arvelle Therapeutics for $960 million
Angelini Pharma will have the exclusive license to commercialise cenobamate in the European Union and other countries in the…
Brazilian Clinics plans deal with Bharat Biotech for five million doses of Covaxin
A team from ABCVAC will travel to India for further discussions with Bharat Biotech, as per reports
DoP issues revised public procurement guidelines
The objective is to further encourage the 'Make in India' and promote the manufacturing and production of goods and services in…
Drug activist group AIDAN raises concerns over EUA for COVAXIN
Urging the DCGI to reconsider the recommendations of the SEC in granting the REU approval to COVAXIN, it has aked the drug…
Reverse brain drain: Accelerated by COVID-19
Ankit Goyal, Healthcare and Lifesciences Leader India, Heidrick & Struggles finds that leadership hiring is attracting…